Nutriband Inc. (NTRB) vs OnKure Therapeutics, Inc. (OKUR)

Nutriband Inc. and OnKure Therapeutics, Inc. are both Biotechnology companies. Nutriband Inc. and OnKure Therapeutics, Inc. are of similar size ($118.7M and $115.2M). OnKure Therapeutics, Inc. has the higher net margin (0.00% vs −430.4%) and the higher return on invested capital (0.00% vs −227.9%). Across the 14 metrics below, OnKure Therapeutics, Inc. leads on 10 and Nutriband Inc. on 4.

Valuation

Metric NTRB OKUR Biotechnology median
P/E n/m n/m 7.88
P/S 60.12 n/m 11.47
P/B 18.26 0.84 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.52 0.74
EV/Sales 58.11 n/m 10.73
Earnings yield (7.16%) (120.69%) (28.84%)
Free cash flow yield (3.74%) (33.10%) (23.03%)

Profitability

Metric NTRB OKUR Biotechnology median
Gross margin 33.14% 0.00% 65.16%
Operating margin (435.57%) 0.00% 0.00%
Net margin (430.43%) 0.00% 0.00%
Free cash flow margin (224.54%) 0.00% 0.00%
Return on equity (100.79%) (46.91%) (57.72%)
Return on assets (84.56%) (44.24%) (49.22%)
Return on invested capital (227.92%) 0.00% 0.00%

Growth

Metric NTRB OKUR Biotechnology median
Revenue growth (TTM) (37.25%) — 5.64%
EPS growth (last fiscal year) (160.61%) 71.20% —
Revenue growth, 5-year CAGR 16.63% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NTRB OKUR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.21 26.75 4.73
Net debt to EBITDA 0.56 0.95 0.96

Dividend

Metric NTRB OKUR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NTRB OKUR Biotechnology median
Market cap 115.24m 118.65m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack